Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.01B P/E 32.29 EPS this Y - Ern Qtrly Grth 41.20%
Income 1.43B Forward P/E - EPS next Y - 50D Avg Chg -1.00%
Sales 18.22B PEG - EPS past 5Y - 200D Avg Chg 9.00%
Dividend N/A Price/Book 3.77 EPS next 5Y - 52W High Chg -10.00%
Recommedations - Quick Ratio 0.82 Shares Outstanding 382.08M 52W Low Chg 66.00%
Insider Own - ROA 5.12% Shares Float 358.72M Beta 1.03
Inst Own 0.01% ROE 14.44% Shares Shorted/Prior -/- Price 7.75
Gross Margin 37.89% Profit Margin 7.87% Avg. Volume 3,787 Target Price -
Oper. Margin 13.42% Earnings Date Jun 5 Volume 636 Change -2.78%
About ELEKTA UNSP ADR EACH REPR 1 ORD

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.